Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Clinical DNA flow cytometry.

B Tribukait

    Medical Oncology and Tumor Pharmacotherapy
    |January 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Tumor DNA content distributions vary by cancer type, indicating different developmental paths. DNA values correlate with tumor cell proliferation and patient prognosis, especially in bladder and cervical cancers.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Release of epidermal growth-factor transforming growth-factor-alpha by ovarian-tumors in-vitro.

    International journal of oncology·2011
    Same author

    Steroid-hormone production and receptors in relation to ki-67, p53, s-phase fraction and ploidy in epithelial ovarian-tumors.

    International journal of oncology·2011
    Same author

    Diagnostic and prognostic implications of DNA ploidy and S-phase evaluation in the assessment of malignancy in biliary strictures.

    Endoscopy·2006
    Same author

    Colorectal cancer in colonic Crohn's disease--high frequency of DNA-aneuploidy.

    Anticancer research·2005
    Same author

    Low IL-1alpha expression in bladder cancer tissue and survival.

    European urology·2003
    Same author

    Age- and site-dependent cell cycle composition of the normal human colonic mucosa.

    Anticancer research·2003

    Area of Science:

    • Oncology
    • Cytogenetics
    • Cancer Biology

    Background:

    • Tumor DNA content analysis reveals distinct distribution patterns: diploid-near diploid, exponential (triploid-tetraploid), and log-normal (triploid-tetraploid).
    • These patterns are observed in various cancers, including non-Hodgkin's lymphoma, prostate, colon, breast, cervix, and testicular carcinomas, suggesting diverse tumor development.
    • Within aneuploid tumors, different DNA distributions can coexist and may correlate with tumor grade, as seen in bladder carcinoma.

    Purpose of the Study:

    • To investigate the relationship between modal DNA values and tumor development across different cancer types.
    • To explore the correlation between DNA content distribution, chromosome number, and S-phase fraction in tumors.
    • To assess the prognostic significance of modal DNA values and S-phase fraction in specific cancers.

    Related Experiment Videos

    Main Methods:

    • Flow cytometry was used to determine modal DNA values and DNA distributions in tumor samples.
    • Chromosome analysis was performed to compare with modal DNA values.
    • S-phase fraction was quantified and correlated with DNA content and clinical outcomes.

    Main Results:

    • Tumors exhibited three main DNA distribution patterns: diploid-near diploid, exponential, and log-normal.
    • Modal DNA values were approximately 10% higher than expected from modal chromosome numbers, independent of technical factors or chromosome size.
    • Near-diploid malignant cells can exist within grossly aneuploid tumors, and modal DNA values correlate with S-phase fraction, impacting patient prognosis.

    Conclusions:

    • The observed variations in tumor DNA content distributions reflect fundamental differences in tumor development.
    • Modal DNA values and S-phase fraction are important indicators of tumor cell proliferation and have prognostic value.
    • Further investigation into DNA content analysis can enhance understanding of tumor biology and clinical outcomes.